Andera Partners participates in the €45 Million Series B Financing of Grey Wolf Therapeutics, led by Pfizer Ventures, to Advance First-of-its-Kind Neoantigen Creation Approaches

Carbios strengthens Executive Committee in pivotal year for industrial and commercial development

Destiny Pharma: US Center for Disease Control (CDC) and two major medical journals cite the importance of decolonization in preventing surgical site infections

ONWARD strengthens leadership team with key appointments in clinical & regulatory and marketing

Mainz Biomed launches corporate health program in Germany for ColoAlert

ONWARD announces participation at upcoming events

Carbios and Novozymes strengthen collaboration with long-term exclusive strategic partnership to secure worldwide leadership in biorecycling of PET

Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatment of hypertension

Andera Partners participates in the $138 Million Series C Financing of Amolyt Pharma led by Sofinnova Partners and co-led by Intermediate Capital Group

Proteros receives minority investment from private equity firm Inflexion